tag:blogger.com,1999:blog-8550428.post2279190825721978219..comments2024-03-28T13:38:36.788-04:00Comments on Pharma Marketing Blog: Implications of FDA’s Warning Letter to Novartis Regarding Facebook Share WidgetVladhttp://www.blogger.com/profile/04114063498108633047noreply@blogger.comBlogger8125tag:blogger.com,1999:blog-8550428.post-48126913458876866352011-05-02T15:34:14.469-04:002011-05-02T15:34:14.469-04:00just a point regarding the point about meta data -...just a point regarding the point about meta data -<br /><br />Google still does use meta data from the tags.<br /><br />Keyword tags, for instance, while no longer a direct organic rank factor, can impact the time it takes a site to begin to appear in the results for specific terms.<br /><br />Description tags and title tags are still very important to Google. Description tags often appear as the blurb under a result in the SERP. It's important enough that if you don't provide a description tag - Google will create their own! <br /><br />In my experience, Google, Yahoo and Bing reward sites with higher rank based on how well the site meets the needs of the user. The search algorithms are designed to measure the factors Google ( or another search engine) believe are most important.<br /><br />Given a choice between:<br /><br />1) a well optimized site, with good internal linking and great home page content with no back links or other off page optimization<br /><br />or<br /><br />2) a site with a ton of manufactured back links <br /><br /><br />I'd take option 1 every time. So would Google.<br /><br />In terms of the FDA - I agree with John - it's all about fair balance. I think the FDA recognizes that the channel(s) will continue to modify so trying to regulate channels is a non-starter. <br /><br />Rather then it being evidence of 1990's understanding - I think it reflects the realities of ongoing technology changes.John Griffithhttp://www.pharmaceuticalseo.comnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-75606694186559581202010-08-10T11:05:19.730-04:002010-08-10T11:05:19.730-04:00Ooops - (Disregard those 2 last lines - forgot to ...Ooops - (Disregard those 2 last lines - forgot to delete them) The questions was raised. Here it is again:<br /><br />Which raises another question: Is this as an important issue as the FDA's letter implies? Is the FDA truly up to snuff, or is this a reflection of late 1990s understanding of the Web.PhilBaumannhttps://www.blogger.com/profile/13168188607039308162noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-61055135986542010562010-08-10T10:30:44.871-04:002010-08-10T10:30:44.871-04:00Sorry, Phil. What was the question?Sorry, Phil. What was the question?PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-18011261258512788592010-08-10T09:59:05.964-04:002010-08-10T09:59:05.964-04:00Hi John
Just a point regarding meta *tags* and Go...Hi John<br /><br />Just a point regarding meta *tags* and Google Search:<br /><br />According to Matt Cutts, head of Web spam at Google, Google does not really use the keyword meta tag in its search.<br /><br />More here:<br /><br />http://www.mattcutts.com/blog/keywords-meta-tag-in-web-search/<br /><br />Other search engines might, but Google doesn't. Meta Description might be used, but keyword meta tags aren't really used in their keyword ranking algorithm.<br /><br />If you think about it, the Web and search engines have dramatically evolved over the last 15 years, and so it makes sense that the early need for HTML meta data isn't nearly as important all other off-site meta data (eg links, backtweets, etc.)<br /><br />Which raises another question: Is this as an important issue as the FDA's letter implies? Is the FDA truly up to snuff, or is this a reflection of late 1990s understanding of the Web.<br /><br />That is: aren't there other priorities at this point?<br />(Eileen's point about fair balance is duly noted - my question goes to the true impact here: Does this *really* protect the public?)<br /><br />So here's the question: <br /><br />Which is <br /><br />@PhilBaumannPhilBaumannhttps://www.blogger.com/profile/13168188607039308162noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-3675048237027566712010-08-06T13:45:52.425-04:002010-08-06T13:45:52.425-04:00The point is no matter where pharma puts informati...The point is no matter where pharma puts information it has to follow DDMAC guidelines for fair balance.Eileen O'Brienhttp://sirensong.sireninteractive.comnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-83571721884736789442010-08-06T13:17:20.747-04:002010-08-06T13:17:20.747-04:00Wendy,
Yes, but... did you see this tweet posted ...Wendy,<br /><br />Yes, but... did you see this tweet posted by @ddwebster, cancer survivor and student of social media:<br /><br />"Ah, chicken or egg debate? RT @pharmaguy: FDA lttr 2 Novartis: Is it msg or medium? w/o medium-specific metadata, FDA wuld not hv seen msg."PharmaGuyhttps://www.blogger.com/profile/10211557578124130640noreply@blogger.comtag:blogger.com,1999:blog-8550428.post-87805246719472468002010-08-06T12:59:15.433-04:002010-08-06T12:59:15.433-04:00Hi John,
It's the message NOT the medium! Thi...Hi John,<br /><br />It's the message NOT the medium! This content did not follow existing FDA guidelines, it just so happened it was to be shared on FAcebook.Eileen O'Brienhttp://sirensong.sireninteractive.comnoreply@blogger.comtag:blogger.com,1999:blog-8550428.post-21760151392445412622010-08-05T18:34:05.154-04:002010-08-05T18:34:05.154-04:00Thanks for this John. Just another example of when...Thanks for this John. Just another example of when it comes to social media and the Internet - really nothing has changed - the SAME RULES APPLY!Anonymoushttps://www.blogger.com/profile/01712567520098554819noreply@blogger.com